[{"Assets_0_Q3_USD":65061000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":2079000000.0,"NetIncomeLoss_1_Q3_USD":-208000000.0,"NetIncomeLoss_3_Q3_USD":736000000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":12000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1018000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1020000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1018000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1018000000.0,"StockholdersEquity_0_Q3_USD":17730000000.0,"EarningsPerShareBasic_1_Q3_USD":-0.27,"EarningsPerShareBasic_3_Q3_USD":0.53,"EarningsPerShareDiluted_1_Q3_USD":-0.27,"EarningsPerShareDiluted_3_Q3_USD":0.53,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":4529000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":14295000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20181101"}]